Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1994 Jun;84(6):890–891. doi: 10.2105/ajph.84.6.890

The urgent need for a vaginal microbicide in the prevention of HIV transmission.

M Potts
PMCID: PMC1614934  PMID: 8203679

Full text

PDF
890

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bird K. D. The use of spermicide containing nonoxynol-9 in the prevention of HIV infection. AIDS. 1991 Jul;5(7):791–796. doi: 10.1097/00002030-199107000-00001. [DOI] [PubMed] [Google Scholar]
  2. Bourinbaiar A. S., Lee-Huang S. Comparative in vitro study of contraceptive agents with anti-HIV activity: gramicidin, nonoxynol-9, and gossypol. Contraception. 1994 Feb;49(2):131–137. doi: 10.1016/0010-7824(94)90088-4. [DOI] [PubMed] [Google Scholar]
  3. Elias C. J., Heise L. L. Challenges for the development of female-controlled vaginal microbicides. AIDS. 1994 Jan;8(1):1–9. doi: 10.1097/00002030-199401000-00002. [DOI] [PubMed] [Google Scholar]
  4. Ellerbrock T. V., Bush T. J., Chamberland M. E., Oxtoby M. J. Epidemiology of women with AIDS in the United States, 1981 through 1990. A comparison with heterosexual men with AIDS. JAMA. 1991 Jun 12;265(22):2971–2975. [PubMed] [Google Scholar]
  5. Feldblum P. J., Weir S. S. The protective effect of nonoxynol-9 against HIV infection. Am J Public Health. 1994 Jun;84(6):1032–1034. doi: 10.2105/ajph.84.6.1032-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hicks D. R., Martin L. S., Getchell J. P., Heath J. L., Francis D. P., McDougal J. S., Curran J. W., Voeller B. Inactivation of HTLV-III/LAV-infected cultures of normal human lymphocytes by nonoxynol-9 in vitro. Lancet. 1985 Dec 21;2(8469-70):1422–1423. doi: 10.1016/s0140-6736(85)92584-x. [DOI] [PubMed] [Google Scholar]
  7. Kreiss J., Ngugi E., Holmes K., Ndinya-Achola J., Waiyaki P., Roberts P. L., Ruminjo I., Sajabi R., Kimata J., Fleming T. R. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA. 1992 Jul 22;268(4):477–482. [PubMed] [Google Scholar]
  8. Roddy R. E., Cordero M., Cordero C., Fortney J. A. A dosing study of nonoxynol-9 and genital irritation. Int J STD AIDS. 1993 May-Jun;4(3):165–170. doi: 10.1177/095646249300400308. [DOI] [PubMed] [Google Scholar]
  9. Rosenberg M. J., Davidson A. J., Chen J. H., Judson F. N., Douglas J. M. Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms. Am J Public Health. 1992 May;82(5):669–674. doi: 10.2105/ajph.82.5.669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rosenberg M. J., Rojanapithayakorn W., Feldblum P. J., Higgins J. E. Effect of the contraceptive sponge on chlamydial infection, gonorrhea, and candidiasis. A comparative clinical trial. JAMA. 1987 May 1;257(17):2308–2312. [PubMed] [Google Scholar]
  11. Stein Z. A. HIV prevention: the need for methods women can use. Am J Public Health. 1990 Apr;80(4):460–462. doi: 10.2105/ajph.80.4.460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Voeller B., Anderson D. J. Heterosexual transmission of HIV. JAMA. 1992 Apr 8;267(14):1917–1919. doi: 10.1001/jama.267.14.1917b. [DOI] [PubMed] [Google Scholar]
  13. Weir S. S., Feldblum P. J., Zekeng L., Roddy R. E. The use of nonoxynol-9 for protection against cervical gonorrhea. Am J Public Health. 1994 Jun;84(6):910–914. doi: 10.2105/ajph.84.6.910. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES